The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hanover Marc Steven since 2007.
The trader's CIK number is 1276243.
At the time of the last reporting, Hanover Marc Steven was the President and COO of Oncternal Therapeutics, Inc.. (stock ticker symbol ONCT).
Also see all insider trading activities at Oncternal Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | GTXI | 0 | $0 | 7,309 | $84,601 | 0 | $0 |
| 2016 | GTXI | 66,813 | $35,369 | 0 | $0 | 0 | $0 |
| 2014 | GTXI | 105,000 | $96,750 | 0 | $0 | 0 | $0 |
| 2009 | GTXI | 3,000 | $31,827 | 0 | $0 | 0 | $0 |
| 2007 | GTXI | 0 | $0 | 228,700 | $5,054,270 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-01-05 | GTXI | Sale | 7,309 | 11.57 | 84,601 |
| 2016-01-26 | GTXI | Buy | 4,000 | .65 | 2,600 |
| 2016-01-25 | GTXI | Buy | 12,813 | .63 | 8,072 |
| 2016-01-19 | GTXI | Buy | 25,000 | .50 | 12,425 |
| 2016-01-14 | GTXI | Buy | 2,900 | .47 | 1,377 |
| 2016-01-15 | GTXI | Buy | 22,100 | .49 | 10,895 |
| 2014-09-23 | GTXI | Buy | 5,000 | .75 | 3,750 |
| 2014-09-17 | GTXI | Buy | 10,000 | .74 | 7,430 |
| 2014-08-20 | GTXI | Buy | 10,000 | 1.00 | 10,000 |
| 2014-08-21 | GTXI | Buy | 10,000 | 1.00 | 10,000 |
| 2014-08-19 | GTXI | Buy | 8,348 | 1.01 | 8,448 |
| 2014-08-15 | GTXI | Buy | 1,652 | 1.00 | 1,652 |
| 2014-08-07 | GTXI | Buy | 20,000 | .92 | 18,340 |
| 2014-08-08 | GTXI | Buy | 10,000 | .95 | 9,530 |
| 2014-08-07 | GTXI | Buy | 30,000 | .92 | 27,600 |
| 2009-01-29 | GTXI | Buy | 1,000 | 10.75 | 10,747 |
| 2009-01-27 | GTXI | Buy | 2,000 | 10.54 | 21,080 |
| 2007-03-14 | GTXI | Sale | 228,700 | 22.10 | 5,054,270 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hanover Marc Steven (President and COO of Oncternal Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.